REFERENCES
- American Psychiatric Association Task Force . 1990 . Benzodiazepine Dependency, Toxicity, and Abuse. Washington , D.C. : American Psychiatric Association Press. .
- Ballenger , J. 1993 . Issues in the clinical use of alprazolam . Journal of Clinical Psychiatry , 54 ( 10 ) : 3 – 101 . (Suppl)
- California Medical Association-BMQA . 1985 . Guidelines for prescribing controlled substances for chronic conditions, a joint statement by the BMQA and CMA 5 – 6 . MBC Action Report BMQA, November
- Hollister , L. , Miiller-Derlinghausen , B. , Rickels , K. and Shader , R. 1993 . Clinical uses of benzodiazepines . Journal of Clinical Psychophar-macology , 13 ( 3 ) : 1 – 169 . Suppl. 1
- Ikeda , R. 1994 . Unpublished data from Board of Medical Examiner records. (Manuscript in preparation)
- Katon , W. 1989 . Panic Disorder in the Medical Setting. Washington , D.C. : U.S. GPO. . Department of Health and Human Services Pub. No. (ADM) 89–1629
- Roy-Byrne , P. and Cowley , D. , eds. 1991 . Benzodiazepines in Clinical Practice: Risks and Benefits. Washington , D.C. : American Psychiatric Association Press. .
- Wesson , D. and Smith , D. E. 1990 . Prescription drug abuse: Patient, physician, and cultural responsibilities . Western Journal of Medicine , 152 ( 5 ) : 613 – 16 .
- Woods , J. H. , Katz , J. and Winger , G. 1992 . Benzodiazepines: Use, abuse and consequences . Pharmacological Reviews , 44 ( 2 ) : 151 – 347 .